Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danoprevir Sodium Tablets Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection
NCT04345276Phase 4Completed
- Sponsor
- Huoshenshan Hospital
- Start
- Mar 2020
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of danoprevir in coronavirus disease 2019 (COVID-19), sponsored by Huoshenshan Hospital. Started Mar 2020; status: completed.
02
Drugs
danoprevir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04345276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04345276.